Literature DB >> 30461031

Right atrial position of a return electrode for bipolar ablation of the left posterosuperior process ventricular tachycardia.

Piotr Futyma1, Ryszard Głuszczyk1, Marian Futyma1, Piotr Kułakowski1,2.   

Abstract

INTRODUCTION: Radiofrequency (RF) catheter ablation (RFCA) of ventricular tachycardia (VT) is an effective method of treatment. However, when arrhythmia has ischemic etiology and originates from the posterosuperior process (PSP) of the left ventricular (LV) base, ablation performed with conventional unipolar energy sources may be challenging or impossible. METHOD AND RESULT: A 67-year-old male after six unsuccessful RFCA for highly symptomatic VT originating from PSP of LV base underwent successful RFCA using multiple bipolar RF applications delivered between two electrodes located at LV endocardium and adjacent right atrial sites.
CONCLUSION: This case report shows that bipolar RFCA can be used for safe and successful treatment of VT originating from deep PSP of LV base.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  LV base; bipolar ablation; catheter ablation; posterosuperior process; ventricular tachycardia

Mesh:

Year:  2018        PMID: 30461031     DOI: 10.1111/pace.13554

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Bipolar ablation of therapy-refractory ventricular arrhythmias: application of a dedicated approach.

Authors:  Shinwan Kany; Fares Alexander Alken; Ruben Schleberger; Jakub Baran; Armin Luik; Annika Haas; Elena Ene; Thomas Deneke; L Dinshaw; Andreas Rillig; Andreas Metzner; Bruno Reissmann; Hisaki Makimoto; Tilko Reents; Miruna Andrea Popa; Isabel Deisenhofer; Roman Piotrowski; Piotr Kulakowski; Paulus Kirchhof; Katharina Scherschel; Christian Meyer
Journal:  Europace       Date:  2022-07-15       Impact factor: 5.486

2.  To the Editor- Bipolar ablation of refractory VT circuits: Current opportunities and limitations.

Authors:  Piotr Futyma; Piotr Kułakowski
Journal:  HeartRhythm Case Rep       Date:  2019-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.